AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Envoy Medical, Inc. Class A Common Stock
XNAS · usd
SIC 3842 · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
FIGI BBG00Z6RQKZ5
0.60▼ 0.00 (-0.07%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
0.60
Day's Range
0.54 – 0.62
52-Week Range
0.36 – 0.95
Volume
692.6K
Avg Volume
95.7K
Share Statistics
Shares Outstanding
Employees
47
Exchange
XNAS
Listed
2023-10-02
Share count as of August 10, 2026

Envoy Medical, Inc. Class A Common Stock (COCH) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Envoy Medical, Inc. Class A Common Stock (COCH)
What is Envoy Medical, Inc. Class A Common Stock's Market Cap?
Envoy Medical, Inc. Class A Common Stock's Market Cap is $46.0M, based on as-reported figures from SEC (XBRL) filings.
What is Envoy Medical, Inc. Class A Common Stock's Enterprise Value?
Envoy Medical, Inc. Class A Common Stock's Enterprise Value is $42.6M, based on as-reported figures from SEC (XBRL) filings.
What is Envoy Medical, Inc. Class A Common Stock's Price / Sales?
Envoy Medical, Inc. Class A Common Stock's Price / Sales is 190.7×, based on as-reported figures from SEC (XBRL) filings.
What is Envoy Medical, Inc. Class A Common Stock's EV / Revenue?
Envoy Medical, Inc. Class A Common Stock's EV / Revenue is 176.9×, based on as-reported figures from SEC (XBRL) filings.
What is Envoy Medical, Inc. Class A Common Stock's EV / EBITDA?
Envoy Medical, Inc. Class A Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Envoy Medical, Inc. Class A Common Stock's Revenue (TTM)?
Envoy Medical, Inc. Class A Common Stock's Revenue (TTM) is $241.0K, based on as-reported figures from SEC (XBRL) filings.
What is Envoy Medical, Inc. Class A Common Stock's Net Income (TTM)?
Envoy Medical, Inc. Class A Common Stock's Net Income (TTM) is -$23.8M, based on as-reported figures from SEC (XBRL) filings.
What is Envoy Medical, Inc. Class A Common Stock's EBITDA?
Envoy Medical, Inc. Class A Common Stock's EBITDA is -$22.0M, based on as-reported figures from SEC (XBRL) filings.
What is Envoy Medical, Inc. Class A Common Stock's Diluted EPS (TTM)?
Envoy Medical, Inc. Class A Common Stock's Diluted EPS (TTM) is -0.31, based on as-reported figures from SEC (XBRL) filings.
What is Envoy Medical, Inc. Class A Common Stock's EBITDA Margin?
Envoy Medical, Inc. Class A Common Stock's EBITDA Margin is -9115.4%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · COCHAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Net revenues—
YoY growth-34.6%—+78.6%-25.0%
Costs and operating expenses:
Cost of goods sold—
Research and development—
Sales and marketing—
General and administrative—
Total costs and operating expenses—
% of revenue11019.6%—8613.3%13690.5%
Operating loss—
% of revenue-10919.6%—-8513.3%-13590.5%
Other income (expense):
Change in fair value of forward purchase agreement warrant liability—
Loss on offering and change in fair value of private warrant liability———
Change in fair value of publicly traded warrant liability—
Interest expense (related party)——
Other income (expense), net—
Total other income (expense), net—
Net loss
% of revenue-11729.4%—-8781.3%-15433.3%
Cumulative preferred dividends—
Net loss attributable to common stockholders, basic—
Net loss attributable to common stockholders, diluted—
Net loss per share attributable to common stockholders, basic—
Net loss per share attributable to common stockholders, diluted—